Single User

Cystic Fibrosis 2015-2020

Lung, Respiratory & Breathing Disorders

Epiomic Insights for Cystic Fibrosis provides you with a top line snapshot of the market potential for this problematic, genetic disorder. With current treatments merely easing the symptoms, the ability to quantify potential patients in need of an innovative curative therapy is essential for commercial success.

Sourcing data from our Epiomic Patient segmentation database, we are able to reference relevant clinical trial data and patient registries to provide a picture of the total projected prevalent population across 8 major global markets.

This one-page synopsis developed by our team of analysts delivers a current overview of the disease and risk factors with a perspective on the future drivers of the patient population. Gender balance and disease genotypes are also displayed in easy to understand graphics.

This style of report is ideal for companies entering a new market segment or disease area of which they have limited knowledge. Alternatively, companies considering investing in healthcare innovation may benefit from a high-level, accurate overview of the market to determine likely commercial potential of such an investment.